AVILEX PHARMA ApS Financials, key figures and credit report
Gross profit — FY 2025
EBIT -4 240.0 kDKK FY 2025 +11.7% vs 2024
Net debt 12 045.0 kDKK FY 2025 +65.6% vs 2024
Quick ratio 4.7 FY 2025 -0.7 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | 45 479.00 | ||||
| Other operating income | 1 987.00 | ||||
| Gross profit | 1 987.00 | 45 479.00 | |||
| Costs of management | -3 200.00 | -7 255.00 | -1 673.00 | - 627.00 | - 728.00 |
| Other operating expenses | -7 472.00 | -3 366.00 | -4 361.00 | -4 176.00 | -3 512.00 |
| EBIT | -8 685.00 | 34 858.00 | -6 034.00 | -4 803.00 | -4 240.00 |
| Other financial income | 77.00 | 3 979.00 | 88.00 | 1 896.00 | 67.00 |
| Other financial expenses | -1 922.00 | -2 176.00 | -2 754.00 | -1 828.00 | -1 647.00 |
| Pre-tax profit | -10 530.00 | 36 661.00 | -8 700.00 | -4 735.00 | -5 820.00 |
| Income taxes | 3 214.00 | -8 061.00 | 1 944.00 | 307.00 | 1 290.00 |
| Net earnings | -7 316.00 | 28 600.00 | -6 756.00 | -4 428.00 | -4 530.00 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Investments total | |||||
| Long term receivables total | |||||
| Inventories total | |||||
| Prepayments and accrued income | 64.00 | ||||
| Current other receivables | 605.00 | 362.00 | 516.00 | 164.00 | 173.00 |
| Current deferred tax assets | 4 437.00 | 1 407.00 | 2 780.00 | 1 328.00 | 1 290.00 |
| Short term receivables total | 5 106.00 | 1 769.00 | 3 296.00 | 1 492.00 | 1 463.00 |
| Cash and bank deposits | 598.00 | 29 827.00 | 24 579.00 | 20 067.00 | 16 928.00 |
| Cash and cash equivalents | 598.00 | 29 827.00 | 24 579.00 | 20 067.00 | 16 928.00 |
| Balance sheet total (assets) | 5 704.00 | 31 596.00 | 27 875.00 | 21 559.00 | 18 391.00 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 409.00 | 470.00 | 470.00 | 470.00 | 470.00 |
| Retained earnings | -21 144.00 | -24 153.00 | 4 447.00 | -2 309.00 | -6 737.00 |
| Profit of the financial year | -7 316.00 | 28 600.00 | -6 756.00 | -4 428.00 | -4 530.00 |
| Shareholders equity total | -28 051.00 | 4 917.00 | -1 839.00 | -6 267.00 | -10 797.00 |
| Non-current loans from credit institutions | 25 867.00 | 19 963.00 | 22 007.00 | 23 829.00 | 25 293.00 |
| Non-current other liabilities | 5 110.00 | 4 320.00 | |||
| Non-current liabilities total | 30 977.00 | 24 283.00 | 22 007.00 | 23 829.00 | 25 293.00 |
| Current loans from credit institutions | 1.00 | 24.00 | 4 967.00 | 3 513.00 | 3 680.00 |
| Current trade creditors | 2 567.00 | 2 121.00 | 2 422.00 | 223.00 | 68.00 |
| Other non-interest bearing current liabilities | 210.00 | 251.00 | 318.00 | 261.00 | 147.00 |
| Current liabilities total | 2 778.00 | 2 396.00 | 7 707.00 | 3 997.00 | 3 895.00 |
| Balance sheet total (liabilities) | 5 704.00 | 31 596.00 | 27 875.00 | 21 559.00 | 18 391.00 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated